Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.
Prondzynski M, Lemoine MD, Zech AT, Horváth A, Di Mauro V, Koivumäki JT, Kresin N, Busch J, Krause T, Krämer E, Schlossarek S, Spohn M, Friedrich FW, Münch J, Laufer SD, Redwood C, Volk AE, Hansen A, Mearini G, Catalucci D, Meyer C, Christ T, Patten M, Eschenhagen T, Carrier L.
Prondzynski M, et al. Among authors: redwood c.
EMBO Mol Med. 2022 Aug 8;14(8):e16423. doi: 10.15252/emmm.202216423.
EMBO Mol Med. 2022.
PMID: 35938313
Free PMC article.
No abstract available.